25
Participants
Start Date
June 29, 2022
Primary Completion Date
July 29, 2024
Study Completion Date
July 30, 2024
CAFMONO supplementation
"CAFMONO supplementation - random blind acute intake of in individual dose providing 3mg/kg BM of CAF.~CAFMONO - Caffeine (anhydrous caffeine), Ostrovit Sp. z o.o., Zambrów, POLAND"
CAFMIPS_1 supplementation
"CAFMIPS\_1 supplementation - random blind acute intake of in individual dose providing 3mg/kg BM of CAF.~CAFMIPS\_1 - Olimp Redweiler, Olimp Laboratories Sp. z o.o., Dębica, POLAND~CAFMIPS\_1 - Olimp Redweiler, Olimp Laboratories Sp. z o.o., Dębica, POLAND"
CAFMIPS_2 supplementation
"CAFMIPS\_2 supplementation - random blind acute intake of in individual dose providing 3mg/kg BM of CAF.~CAFMIPS\_2 - Muscle Clinic Furious, Noblepharma UG, BerlinVertrieb, GERMANY."
Placebo treatment
Placebo treatment - random blind acute intake of placebo preparation. Placebo will match the remaining test preparations with taste, colour and consistency, however it will be free of caffeine and any other substances possessing ergogenic potential.
RECRUITING
Department of Sports Dietetics, Poznan University of Physical Education, Poznan
National Science Centre, Poland
OTHER_GOV
Poznan University of Life Sciences
OTHER
Poznan University of Physical Education
OTHER